Patents

US10202374: 6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors

Filing Date: 24-08-2016

Issue Date: 12-02-2019

Applicant: CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu

Patent No: US10202374

Application No: 15/121328

Inventor(s): Vishwakarma Ram Asrey, Bharate Sandip Bibishan, Bhushan Shashi, Yadav Rammohan Rao, Guru Santosh Kumar, Joshi Prashant

Country: United States of America

Related Patents

CA2625437: Transesterification catalyst, process foer preparation thereof and a process for transesterification using the catalyst
CN201580069141: Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
DE2550275: Pyrrolo[2,1-c][1,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety as potential antitumour agent and process for the preparation thereof
DE2676287: Selective detection and analysis of small molecules
DE3039082: A squaraine based fluorescent probe for selective labeling and sensing of serum albumin proteins, pH monitoring and thiol imaging in cells and a process for the preparation thereof